欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此洽谈。
;如有合作推广需求,请近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Journal of Gynecologic Oncology J GYNECOL ONCOL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.1
51人评分
我要评分
声誉 7.1 影响力 5.0 速度 7.1 | |||||||||||||||||||||||||||||||
期刊ISSN | 2005-0380 | ![]() 蝌蝌APP,让您与同行交流更轻松
![]() | ||||||||||||||||||||||||||||||
E-ISSN | 2005-0399 | |||||||||||||||||||||||||||||||
2024-2025最新影响因子 (数据来源于搜索引擎) | 3.7 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
实时影响因子 | 截止2025年5月19日:3.524 | |||||||||||||||||||||||||||||||
2024-2025自引率 | 8.10%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
五年影响因子 | 3.5 | |||||||||||||||||||||||||||||||
JCI期刊引文指标 | 1.12 | |||||||||||||||||||||||||||||||
h-index | 30 | |||||||||||||||||||||||||||||||
CiteScore ( 2025年最新版) |
| |||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||
期刊官方网站 | https://ejgo.org/ | |||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||
期刊投稿网址 | https://www.editorialmanager.com/JGYNECOLONCOL | |||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Journal of Gynecologic Oncology的语言要求,还能让Journal of Gynecologic Oncology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Journal of Gynecologic Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:没有 文章处理费豁免:没有 其他费用:查看说明 期刊主题关键词:gynecology、neoplasms、oncology、genital neoplasms、female、obstetrics and gynecology 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardDouble anonymous peer review | |||||||||||||||||||||||||||||||
通讯方式 | KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY, 102-HO, 55-5, NONHYEON-DONG, GANGNAM-GU, SEOUL, SOUTH KOREA, 135-010 | |||||||||||||||||||||||||||||||
出版商 | Korean Society of Gynecologic Oncology and Colposcopy | |||||||||||||||||||||||||||||||
涉及的研究方向 | ONCOLOGY-OBSTETRICS & GYNECOLOGY | |||||||||||||||||||||||||||||||
出版国家或地区 | SOUTH KOREA | |||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||
出版周期 | Quarterly | |||||||||||||||||||||||||||||||
出版年份 | 2008 | |||||||||||||||||||||||||||||||
年文章数 | 99点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
Gold OA文章占比 | 99.59% | |||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 95.96% | |||||||||||||||||||||||||||||||
WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院期刊分区趋势图
| |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2005-0380%5BISSN%5D | |||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: >12周,或约稿 | |||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 较易 | |||||||||||||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:没有 文章处理费豁免:没有 其他费用:查看说明 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Journal of Gynecologic Oncology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | Bevacizumab combined with chemotherapy could be superior to chemotherapy alone in relapsed ovarian cancer after PARPi: evidence from a multi-center propensity score-matched analysis Author: Zhong, Lin; Wang, Haixia; Lei, Cuirong; Zou, Dongling Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025; Vol. 36, Issue 3, pp. -. DOI: 10.3802/jgo.2025.36.e36 PubMed DOI |
2. | Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: a systematic review and meta-analysis Author: Zhang, Xinyue; Yang, Jie; Li, Sijian; Zhang, Tianyu; Yang, Jiaxin Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025; Vol. 36, Issue 3, pp. -. DOI: 10.3802/jgo.2025.36.e49 PubMed DOI |
3. | Humanized patient-derived xenograft mouse model bearing ovarian clear cell carcinoma Author: Yuan, Zhen; Zhou, Huimei; Cao, Dongyan; Yang, Jiaxin; Liu, Qian Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025; Vol. 36, Issue 3, pp. -. DOI: 10.3802/jgo.2025.36.e40 PubMed DOI |
4. | Clinical trial comparing the use of Orcellex® Brush versus Cervex-Brush® on vaginal vault smear cytology adequacy rate in patients treated with radiotherapy for cervical cancer Author: So, Yick Ling; He, Mung Yuen; Hui, Sze Ki; Yu, Ellen Lok-man Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025; Vol. 36, Issue 3, pp. -. DOI: 10.3802/jgo.2025.36.e43 PubMed DOI |
5. | Different surgical methods for FIGO stage IVB cervical cancer patients receiving chemotherapy: a population-based study Author: Li, Haoran; Wu, Jiao; Xu, Qing; Chen, Yixin; Cheng, Xi Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025; Vol. 36, Issue 3, pp. -. DOI: 10.3802/jgo.2025.36.e42 PubMed DOI |
6. | Toripalimab combined with bevacizumab plus chemotherapy as first-line treatment for refractory recurrent or metastatic cervical cancer: asingle-arm, open-label, phase II study (JS001-ISS-CO214) Author: Li, Chen; Liu, Shikai; He, Yonglan; Yao, Hairong; Yuan, Zhilin; Yang, Jiaxin; Cao, Dongyan; Cheng, Ninghai; Yang, Junjun; Peng, Peng; Xiang, Yang Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025; Vol. 36, Issue 3, pp. -. DOI: 10.3802/jgo.2025.36.e44 PubMed DOI |
7. | Management for perioperative complications of diaphragmatic surgery in ovarian cancer at a Chinese tertiary cancer center Author: Ha, Xinyu; Feng, Zheng; Wu, Yangjun; Liu, Ziqi; Ju, Xingzhu; Wen, Hao; Wu, Xiaohua Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025; Vol. 36, Issue 3, pp. -. DOI: 10.3802/jgo.2025.36.e109 PubMed DOI |
8. | Application value of personalized 3D printing vaginal model for the Image-guided adaptive brachytherapy of cervical cancer Author: Cai, Zhantuo; Wu, Qiuyan; Yang, Xinglong; Qin, Qinghua; Zhang, Yiqian; Li, Zhouyu; Li, Mingyi Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025; Vol. 36, Issue 3, pp. -. DOI: 10.3802/jgo.2025.36.e48 PubMed DOI |
9. | The role of radiomics for predicting of lymph-vascular space invasion in cervical cancer patients based on artificial intelligence: a systematic review and meta-analysis Author: Zhao, Mengli; Li, Zhen; Gu, Xiaowei; Yang, Xiaojing; Gao, Zhongrong; Wang, Shanshan; Fu, Jie Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025; Vol. 36, Issue 2, pp. -. DOI: 10.3802/jgo.2025.36.e26 PubMed DOI |
10. | Role of HPV E7/miR-143-3p/SH2D3A pathway in regulating the occurrence and development of cervical cancer Author: Wu, Meiyao; Liu, Renci; Liu, Yao; Shen, Fan; Zhao, Yang; Sheng, Xiujie Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025; Vol. 36, Issue 2, pp. -. DOI: 10.3802/jgo.2025.36.e34 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室